WealthOne’s Novo Nordisk NVO Stock Holding History

WealthOne’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-252	Closed	-$6K	–	390
2018 Q4	$6K	Buy	+252	New	+$5.6K	0.01%	438

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

WealthOne's NVO Position: Q1 2019 in Review

WealthOne sold out of Novo Nordisk (NVO) in Q1 2019, closing a stake of 252 shares — an estimated $6K sold.

WealthOne first reported a position in NVO in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 580 funds tracked by Wall St. Rank hold NVO as of Q1 2019.

WealthOne reported no remaining Novo Nordisk position as of Q1 2019 after selling out during the quarter.
WealthOne sold 252 Novo Nordisk shares in Q1 2019, an estimated $6K.
WealthOne first reported a position in Novo Nordisk in Q4 2018 and held it in 1 quarter.
WealthOne's Novo Nordisk position peaked at $6K in Q4 2018.
580 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2019.

Based on WealthOne's 13F filing for Q1 2019, filed 16 May 2019.